BALA CYNWYD, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that data from the Company’s nomlabofusp Phase 1 studies and Phase 2 dose exploration study, some of which has been previously disclosed, will be presented at […]

TORONTO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Guardian Capital LP (the “Manager“), the manager of Guardian i3 US Quality Growth ETF (the “Fund“), today announced that it has changed the name of the Fund effective immediately to Guardian i3 US Quality Growth Fund (the “Name Change“). There are no changes to the investment objective, strategies

LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced the appointment of Matthias Will, M.D., as Chief Development Officer. Dr. Will is joining Autolus’ executive team and will lead the company’s development organization effective September 30, 2024. “Matthias has a proven

NAPLES, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — Beasley Broadcast Group Inc. (Nasdaq: BBGI), a multi-platform media company (the “Company”), today announced that its Board of Directors (the “Board”) has approved a reverse stock split of its Class A Common Stock and Class B Common Stock (collectively, the “Common Stock”) at a ratio of 1-for-20.

Press Release Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development Advisor Geneva, Switzerland – September 19, 2024 – STALICLA SA, a Swiss neuro precision biotech company dedicated to developing precision medicine-based treatments for neurodevelopmental disorders, announced today that Dr. Paulo Fontoura will be joining their drug development team as Chief

The Importance of 3D-Circuits in Healthcare Doctors and clinicians need the best tools. Hospitals need the best supply contracts and equipment. Everyone benefits from new cutting-edge engineering in medical devices and clinical hardware. In the race to fine-tune healthcare systems and deliver the best patient care, technology plays an enormous role. We’ve found that these

Ottawa, ON, Sept. 19, 2024 (GLOBE NEWSWIRE) — Altea, Canada’s fitness and wellness leader, today announced plans to hire 200 team members in preparation for the highly anticipated opening of Altea Ottawa. Set to open in late 2024, Altea Ottawa, a first-of-its-kind facility spanning 129,000 square-feet at 1660 Carling Avenue (previously Canadian Tire), will provide

MELVILLE, N.Y., Sept. 19, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that its Chief Scientist and Vice President of Research and Development, Francisco Silva, will present at the 21st Annual International Federation for Adipose

NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — Nicholas Wealth, a leading provider of actively managed income ETFs, just announced increased monthly distributions to 8.04% on the Nicholas Fixed Income Alternative ETF (FIAX). Distribution as of 9/18/2024 ETF Ticker Distribution per Share Distribution Rate 30-Day SEC Yield Ex-Date Record Date Payment Date FIAX $ 0.1321

Fullerton Health is proud to announce the launch of its 2023 Sustainability Report. Understanding the urgency of the climate agenda, FHG, in the second year of Sustainability reporting, has incorporated a carbon plan. In addition to highlighting the company’s ongoing efforts to enhance sustainability across its operations in Singapore, the Philippines and beyond, FHG has